Search company, investor...

Predict your next investment

Galen Partners company logo
Private Equity
galen.com

Investments

57

Portfolio Exits

22

Funds

6

About Galen Partners

Galen Partners is a private equity financing firm. The firm focuses on growth equity investments in health care technology-enabled services, medical devices, and specialty pharmaceutical companies.

Headquarters Location

680 Washington Boulevard 11th Floor

Stamford, Connecticut, 06901,

United States

Want to inform investors similar to Galen Partners about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest Galen Partners News

New CEO plans to franchise Newton's Labshares

Sep 13, 2023

Philip Borden, a venture capitalist with roots at Galen Partners, Oxford Bioscience Partners and Frazier Healthcare Partners, took a majority stake in the shared lab space company with private equity firm Pacific Lake Partners and is looking to expand through Greater Boston.

Galen Partners Investments

57 Investments

Galen Partners has made 57 investments. Their latest investment was in CDx Diagnostics as part of their Recap on July 7, 2017.

CBI Logo

Galen Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

7/11/2017

Recap

CDx Diagnostics

Yes

3

4/12/2016

Series C

Ajinomoto Cambrooke

No

4

5/28/2015

Series D

Life Image

$17.5M

No

4

7/29/2013

Unattributed VC - III

Subscribe to see more

$99M

Subscribe to see more

10

4/18/2013

Series C

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/11/2017

4/12/2016

5/28/2015

7/29/2013

4/18/2013

Round

Recap

Series C

Series D

Unattributed VC - III

Series C

Company

CDx Diagnostics

Ajinomoto Cambrooke

Life Image

Subscribe to see more

Subscribe to see more

Amount

$17.5M

$99M

$99M

New?

Yes

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

3

4

4

10

10

Galen Partners Portfolio Exits

22 Portfolio Exits

Galen Partners has 22 portfolio exits. Their latest portfolio exit was Life Image on September 15, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

9/15/2022

Acquired

$99M

10

7/1/2021

Reverse Merger

$99M

4

4/27/2021

Acquired

$99M

10

1/20/2021

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

1/13/2020

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

9/15/2022

7/1/2021

4/27/2021

1/20/2021

1/13/2020

Exit

Acquired

Reverse Merger

Acquired

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

10

4

10

10

10

Galen Partners Acquisitions

2 Acquisitions

Galen Partners acquired 2 companies. Their latest acquisition was Evolve Treatment Centers on January 08, 2020.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

1/8/2020

$99M

Acq - Fin

2

12/10/2003

Series A

Subscribe to see more

$99M

$99M

Subscribe to see more

0

Date

1/8/2020

12/10/2003

Investment Stage

Series A

Companies

Subscribe to see more

Valuation

$99M

$99M

Total Funding

$99M

Note

Acq - Fin

Subscribe to see more

Sources

2

0

Galen Partners Fund History

6 Fund Histories

Galen Partners has 6 funds, including Galen Evolve SPV.

Closing Date

Fund

Fund Type

Status

Amount

Sources

10/15/2019

Galen Evolve SPV

$20M

1

10/15/2019

Galen Partners VI Annex Fund

$99M

10

7/20/2017

Galen CDx SPV II

$99M

10

7/20/2017

Galen CDx SPV III

$99M

10

7/20/2017

Galen CDx SPV

$99M

10

Closing Date

10/15/2019

10/15/2019

7/20/2017

7/20/2017

7/20/2017

Fund

Galen Evolve SPV

Galen Partners VI Annex Fund

Galen CDx SPV II

Galen CDx SPV III

Galen CDx SPV

Fund Type

Status

Amount

$20M

$99M

$99M

$99M

$99M

Sources

1

10

10

10

10

Galen Partners Team

8 Team Members

Galen Partners has 8 team members, including , .

Name

Work History

Title

Status

Judith Starkey

Founder

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Judith Starkey

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

Founder

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.